Pasar al contenido principal

NUCLEOTIDO HIDROLASAS EN LA INFECCION POR TRYPANOSOMA. ELUCIDACION DE SU PAPEL EN LAS INTERACCIONES HUESPED-PARASITO

PID2022-142971OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals

  • Castillo, Francisco
  • Ramírez, David
  • Ramos, María C.
  • Martínez-Arribas, Blanca
  • Domingo-Contreras, Elisabeth
  • Mackenzie, Thomas
  • Peña-Varas, Carlos
  • Lindemann, Sven
  • Montero, Fernando
  • Annang, Frederick
  • Vicente, Francisca
  • Genilloud, Olga
  • González-Pacanowska, Dolores
  • Fernández-Godino, Rosario
The SARS coronavirus 2 (SARS-CoV-2) epidemic remains globally active. The emergence of new variants of interest and variants of concern (VoCs), which are potentially more vaccine-resistant and less sensitive to existing treatments, is evident due to their high prevalence. The prospective spread of such variants and other coronaviruses with epidemic potential demands preparedness that can be met by developing fast-track workflows to find new candidates that target viral proteins with a clear in vitro and in vivo phenotype. Mpro (or 3CLpro) is directly involved in the viral replication cycle and the production and function of viral polyproteins, which makes it an ideal target. The biological relevance of Mpro is highly conserved among betacoronaviruses like HCoV-OC43 and SARS-CoV-2, which makes the identification of new chemical scaffolds targeting them a good starting point for designing broad-spectrum antivirals. We report an optimized methodology based on orthogonal cell-free assays to identify small molecules that inhibit the binding pockets of both SARS-CoV-2-Mpro and HCoV-OC43-Mpro; this blockade correlates with antiviral activities in HCoV-OC43 cellular models. By using such a fast-tracking approach against the Open Global Health Library (Merck KGaA), we have found evidence of the antiviral activity of compound OGHL98. In silico studies dissecting intermolecular interactions between OGHL98 and both proteases and comprising docking and molecular dynamics simulations (MDSs) concluded that the binding mode was primarily governed by conserved H-bonds with their C-terminal amino acids and that the rational design of OGHL98 has potential against VoCs proteases resistant to current therapeutics., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. DG-P’s laboratory and research have been funded by the European Commission—Next Generation EU (regulation EU 2020/2094) through CSIC’s Global Health Platform (PTI Salud Global), the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014), and the MCIN/AEI/10.13039/501100011033, and by the grants PID2019-109623RB-I00, MCIN/AEI/10.13039/501100011033, and FEDER Una manera de hacer Europa (2016- 79957-R), and PID2022-142971OB-I00, MCIN/AEI/10.13039/501100011033/FEDER, UE, and by the Junta de Andalucía (BIO-199). DR’s research has been funded by the Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT), grant number 1220656, and the Agencia Nacional de Investigación y Desarrollo (ANID), grant number COVID0199., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Collective and diverted total synthesis of the strasseriolides: A family of macrolides endowed with potent antiplasmodial and antitrypanosomal activity

  • Isak, Daniel
  • Schwartz, Leyah A.
  • Schulthoff, Saskia
  • Pérez-Moreno, Guiomar
  • Bosch-Navarrete, Cristina
  • González-Pacanowska, Dolores
  • Fürstner, Alois
The strasseriolide macrolides show promising in vitro and in vivo activities against P. falciparum and T. cruzi, the parasites causing malaria and Chagas disease, respectively. However, the as yet poor understanding of structure/activity relationships and the fact that one family member proved systemically toxic for unknown reasons render a more detailed assessment of these potential lead compounds difficult. To help overcome these issues, a collective total synthesis was devised. The key steps consisted of a ring closing alkyne metathesis (RCAM) reaction to forge a common macrocyclic intermediate followed by a hydroxy-directed ruthenium catalyzed trans-hydrostannation of the propargyl alcohol site thus formed. The resulting alkenyltin derivative served as the central node of the synthesis blueprint, which could be elaborated into the natural products themselves as well as into a set of non-natural analogues according to the concept of diverted total synthesis. The recorded biological data confirmed the potency of the compounds and showed the lack of any noticeable cytotoxicity. The “northern” allylic alcohol subunit was recognized as an integral part of the pharmacophore, yet it provides opportunities for chemical modification., Generous financial support by the Max-Planck-Gesellschaft is gratefully acknowledged. Support was also provided by grant PID2022-142971OB-I00 funded by MCIN/AEI/ 10.13039/501100011033/ERDF, UE and by the Junta de Andalucía (BIO-199)., Open Access funding enabled and organized by Projekt DEAL., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pharmacophore identification and structure-activity relationship analysis of a series of substituted azaindoles as inhibitors of Trypanosoma brucei

  • Ferrins, Lori
  • Díaz, Rosario
  • Cordon-Obras, Carlos
  • Rojas-Barros, Domingo I.
  • Quotadamo, Antonio
  • Oehme, Daniel P.
  • Ceballos-Pérez, Gloria
  • Swaminathan, Uma
  • Pérez-Moreno, Guiomar
  • Bosch-Navarrete, Cristina
  • García-Hernández, Raquel
  • Gómez-Liñán, Claudia
  • Saura, Andreu
  • Ruiz-Pérez, Luis Miguel
  • Gamarro, Francisco
  • Martínez-Martínez, María S.
  • Manzano, Pilar
  • González-Pacanowska, Dolores
  • Navarro, Miguel
  • Pollastri, Michael P.
Human African trypanosomiasis is among the World Health Organization’s designated neglected tropical diseases. Repurposing strategies are often employed in academic drug discovery programs due to financial limitations, and in this instance, we used human kinase inhibitor chemotypes to identify substituted 4-aminoazaindoles, exemplified by 1. Structure–activity and structure–property relationship analysis, informed by cheminformatics, identified 4s as a potent inhibitor of Trypanosoma brucei growth. While 4s appeared to be fast acting and cidal in the in vitro assays, it failed to cure a murine model of infection. Preliminary efforts to identify the potential mechanism of action of the series pointed to arginine kinase, though, as we demonstrate, this does not appear to be the sole target of our compounds. This comprehensive approach to drug discovery, encompassing cheminformatics, structure–potency and structure–property analysis, and pharmacophore identification, highlights our multipronged efforts to identify novel lead compounds for this deadly disease., The authors acknowledge funding from the National Institute of Allergy and Infectious Diseases (M.P.P., M.N., and D.G.-P., R01AI114685; M.P.P., R21AI127594 and R01AI124046), the Spanish Ministerio de Ciencia, Innovación y Universidades, (D.G-P., Grant PID2022-142971OB-I00, funded by MCIN/AEI/10.13039/501100011033/FEDER, UE; M.N., SAF2015-71444), the Subdirección General de Redes y Centros de Investigación Cooperativa (RICET) (M.N., RD16/0027/0019; D.G.-P., RD16/0027/0014), RTI2018-098834-B-I00 (MINCIU-FEDER) to M.N., and RTI2018-097210-B-I00 (MINCIU-FEDER) to F.G., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A cytidine deaminase-like protein modulates pyrimidine nucleotide homeostasis in Trypanosoma brucei

  • Moro-Bulnes, Ana
  • Bosch-Navarrete, Cristina
  • Antequera-Parrilla, Pablo
  • Castanys, Santiago
  • Vidal, Antonio E.
  • Ruiz-Pérez, Luis Miguel
  • Pérez-Moreno, Guiomar
  • González-Pacanowska, Dolores
Pyrimidine nucleotide homeostasis is critical for DNA replication and cell viability, yet its regulation in Trypanosoma brucei, the causative agent of African trypanosomiasis, remains poorly understood. Here, we characterize a T. brucei cytidine deaminase-like protein (TbCDA-like), a kinetoplastid-specific enzyme absent in mammals, that harbors a deaminase domain and a zinc-finger CCCH motif. Using RNA interference (RNAi) and overexpression approaches, we demonstrate that TbCDA-like modulates pyrimidine nucleotide pools, influencing both ribonucleotide and deoxyribonucleotide profiles. Overexpression of TbCDA-like resulted in a substantial reduction of dCTP and CTP levels while elevating dTTP and UTP pools, suggesting a role in cytidine derivative deamination. Conversely, RNAi-mediated depletion of TbCDA-like caused CMP accumulation and reduced dTTP levels. Notably, overexpression induced severe cytotoxicity, growth arrest, DNA damage and cell cycle defects, evidenced by sub-G1 populations, increased nuclear H2A phosphorylation and aberrant kinetoplast and nuclear morphologies. Localization studies revealed that TbCDA-like is primarily cytosolic and relocalizes to stress granules upon nutrient deprivation, suggesting a role in RNA metabolism. These findings establish TbCDA-like as a key regulator of pyrimidine nucleotide homeostasis in T. brucei, linking nucleotide imbalances to DNA replication stress and genome instability. Given its absence in mammals, TbCDA-like presents an attractive target for therapeutic intervention against trypanosomiasis., We thank the TrypTag database for the available information regarding the subcellular localization of TbCDA-like. This work was funded by grant PID2019-109623RB-I00 and PID2021-124911OB-I00, the MCIN/AEI/https://doi.org/10.13039/501100011033 and FEDER Una manera de hacer Europa (2016-79957-R), grant PID2022-142971OB-I00 MCIN/ AEI / https://doi.org/10.13039/501100011033 / ERDF, UE and by the Junta de Andalucía (BIO-199). A.M.B. was supported by a Formación del Profesorado Universitario (Ref FPU15/01820) fellowship from the Spanish Government (Ministerio de Educación y Formación Profesional). P. A-P. was supported by a “Formación de Doctores” (BES-2017-082012) fellowship from the Spanish Government (Ministerio de Ciencia e Innovación)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biological evaluation as antimalarial of two families of biscationic compounds featuring two different sulphur linkers

  • Luque Navarro, Pilar María
  • Carrasco-Jiménez, María Paz
  • Parisini, Emilio
  • Lanari, D.
  • Odina, Laura M.
  • Jekabsons, A
  • Perales, Sonia
  • Zelencova-Gopejenko, Diana
  • Pérez-Moreno, Guiomar
  • Bosch-Navarrete, Cristina
  • González-Pacanowska, Dolores
  • López-Cara, Luisa C.
Plasmodium falciparum kinases have been widely studied due to their potential as targets for the discovery of alternatives to artemisinin-combined therapies. Their role in parasite blood-stage replication and their homology with human kinases has led to the exploitation of already tested antitumoral kinase inhibitors as antiplasmodial drugs. Plasmodium falciparum choline kinase (PfCK), a cytosolic enzyme involved in phospholipid synthesis, is a promising target for parasite resistant strains. PfCK uses the host choline and catalyzes its transformation in phosphocholine, a key step for the formation of the lipid membranes required by the new parasite progeny inside the erythrocyte. Previously, we described the synthesis of two libraries (PL and FP) of human choline kinase (hCK) inhibitors, which we generated following a green by design approach. Some of these compounds were found to exhibit antitumoral properties. Here, we evaluated the same compounds as potential inhibitors of PfCK and antimalarial agents. Interestingly, while the compounds of the FP library, which feature a disulphide linker, show PfCK inhibition in the nM range independently of the cationic head (FP3 being the most active compound, PfCK IC<inf>50</inf> = 0.16 μM), they show no effect on infected erythrocytes. On the other hand, the compounds of the PL library, which feature a dithioethane linker, show in vitro activity against the parasite but no inhibitory activity against the isolated enzyme (PL40 exhibits the highest antimalarial activity, with IC<inf>50</inf> = 10 nM). This lack of correlation could be due to either cellular disulphide degradation in vitro or to the existence of alternative targets for the dithioethane library. Considering the previously reported anticancer potential of the PL family and the antiparasitic activity reported herein, these compounds may be considered as good starting points for the development of multifunctional drugs., This research was funded by Convocatoria 2019 Proyectos de I + D + i − RTI Tipo B “Ministerio de Innovacion y Ciencia” grant number PID2019-109294RB-I00 funded by MCIN/ AEI/10.13039/501100011033 and “Convocatoria 2020 Proyectos I + D + i del Programa Operativo FEDER 2020”, grant number B-CTS-216- UGR20. E.P. thanks the ERDF project BioDrug (No. 1.1.1.5/19/A/004). The work was also funded by the Instituto de Salud Carlos III Subdirección General de Redes y Centros de Investigación Cooperativa-Red de Investigación Cooperativa en Enfermedades Tropicales (RICET: RD16/0027/0014), grant PID2022-142971OB-I00, funded by MCIN/AEI/ 10.13039/501100011033/FEDER, UE and by the Junta de Andalucía (BIO-199 and CTS-236). The authors thank the Granada University Library for its financial support. The authors thank the Centro de Supercomputación de la Universidad de Granada (CSIRC) for the computing resources., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1H-Pyrrolo[2,3b]pyridines Inhibitors of Trypanosome Proliferation

  • Bachovchin, Kelly
  • Díaz, Rosario
  • Ceballos-Pérez, Gloria
  • Rojas-Barros, Domingo I.
  • Pérez-Moreno, Guiomar
  • García-Hernández, Raquel
  • Bosch-Navarrete, Cristina
  • Rivers, Mitch
  • Penn, Erica C.
  • Roncal, Norma E.
  • Sciotti, Richard J.
  • Campbell, Robert F.
  • Martínez-Martínez, María S.
  • Manzano, Pilar
  • Ruiz-Pérez, Luis Miguel
  • Navarro, Miguel
  • González-Pacanowska, Dolores
  • Pollastri, Michael P.
  • Ferrins, Lori
  • Singh, Baljinder
Neglected tropical diseases, such as human African trypanosomiasis (HAT), require novel treatments that can populate the clinical pipeline in the event of rising resistance and treatment recrudescence. Following a high-throughput screen of almost 42,000 human kinase inhibitor chemotypes, we identified a 2,4-disubstituted azaindole that had good antiparasitic activity, selectivity, and predicted brain exposure, but that failed to meet our criteria for advancement into an efficacy study. Following hit-to-lead optimization, we arrived at 18a, which offered the best combination of potency, properties, and pharmacokinetic parameters, and, while not curative, this work leads to opportunities for continued optimization for HAT and cutaneous leishmaniasis., The authors acknowledge funding from the National Institute of Allergy and Infectious Diseases (M.P.P., M.N. D.G.-P., and L.F., 2R01AI114685; M.P.P., 1R21AI127594, R01AI124046), the Spanish Ministerio de Economía, Industria y Competitividad, (M.N., SAF2015-71444 P; D.G.-P., PID2019-109623RB-I00 MICIU/AEI/10.13039/501100011033 and PID2022-142971OB-I00 MCIN/AEI/10.13039/501100011033/ERDF, UE), and Subdirección General de Redes y Centros de Investigación Cooperativa (RICET) (M.N., RD16/0027/0019; D.G.-P., RD16/0027/0014). We thank AstraZeneca for the provision of the in vitro ADME and physicochemical properties data included in the manuscript. Use of JChem/ChemAxon software [Product version 20.11.0, ChemAxon (https://www.chemaxon.com)] is acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

DCTPP1 orchestrates dCTP pool dynamics and mtDNA stability in quiescent cells

  • Fernández López, María Belén
  • Pérez-Moreno, Guiomar
  • Martínez-Arribas, Blanca
  • Vidal, Antonio E.
  • Ruiz-Pérez, Luis Miguel
  • González-Pacanowska, Dolores
Defects in nucleotide metabolism and imbalances in deoxynucleotide triphosphate (dNTP) pools are associated with several human diseases, including cancer and mitochondrial disorders. In non-replicative cells, while DNA synthesis is reduced, a continuous supply of nucleotides is essential to sustain mitochondrial DNA (mtDNA) replication and repair. Human all-α dCTP pyrophosphatase 1 (DCTPP1), a nucleotido hydrolase with high specificity for dCTP, plays a critical role in maintaining nucleotide homeostasis, however its participation in mtDNA stability remains unexplored. In this study we performed a detailed analysis of pyrimidine metabolism enzymes in non-dividing cells. We found that during quiescence, DCTPP1 is predominantly localized to mitochondria. Depletion of the enzyme leads to upregulation of the de novo thymidylate synthesis pathway and expansion of both the dCTP and dGTP pools, highlighting its pivotal role in regulating the dNTP balance. To explore the potential therapeutic relevance of these observations, we used an in vitro model of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), a rare mitochondrial disorder caused by thymidine phosphorylase (TP) deficiency and characterized by dCTP depletion and mtDNA loss. Long-term thymidine overloading in quiescent cells (a model mimicking TP deficiency) led to reduced dCTP levels and the depletion of mtDNA, effects that were reversed upon DCTPP1 knockdown. Hence, reduced DCTPP1 levels restored dCTP availability and increased mtDNA copy number. These findings suggest that DCTPP1 plays a critical role in regulating mitochondrial dNTP pools and that down-regulation of the enzyme may serve as a compensatory mechanism in disorders marked by secondary dCTP depletion. DCTPP1 may therefore represent a promising therapeutic target for mitochondrial DNA depletion syndromes such as MNGIE., We thank the IPBLN core facility, especially Laura Montosa for her support with advanced imaging resources and microscopy analysis, and Aurora Constán for her technical assistance. This work was funded by a grant from the Junta de Andalucía (P18 -RT-4870) and by the grant PID2022-142971OB-I00 MCIN/AEI/ https://doi.org/10.13039/501100011033 / ERDF, UE., Peer reviewed